Biblio Discovery — Demo Discovery Service

11 results for "Deepa Bedi"

Showing 1–11 · 0.22 seconds · RSS

  1. Journal Article Full text

    Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells

    Deepa Bedi; Henry J. Henderson; Upender Manne et al.

    Medicines, Vol. 6 No. 2 · 2019 · English · DOAJ

    Background: Immunotherapy has changed the options for the treatment of various cancer types, but not colon cancer. Current checkpoint blockade approaches are ineffective in a large proportion of colon cancer cases, necessitating studies to elucidate its mechanisms and to identify new targets and…

  2. Journal Article

    The immunopeptidome of colon cancer cells treated with topoisomerase inhibiting drug reveals differential as well as common endogenous protein sampling and display of MHC I-associated peptides

    Deepa Bedi; Mohammed Hassan; Alehegne Yirsaw et al.

    Molecular & Cellular Oncology, Vol. 12 No. 1 · 2025 · English · DOAJ Scopus

    Immunotherapy options for microsatellite stable (MSS) colorectal cancer are currently very limited. The lack of detectably unique or altered immunogens in the tumor microenvironment may be a factor. Radiation and chemotherapy may enhance immunotherapy by increasing cancer cell visibility through…

  3. Journal Article Full text

    Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival

    Henry J. Henderson; Balasubramanyam Karanam; Rajeev Samant et al.

    PLOS ONE, Vol. 12 No. 12 · 2017 · English · PLOS Scopus

    The molecular mechanisms involved in breast cancer progression and metastasis still remain unclear to date. It is a heterogeneous disease featuring several different phenotypes with consistently different biological characteristics. Neuroligins are neural cell adhesion molecules that have been…

    Also available at: DOAJ

  4. Journal Article Full text

    Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision Medicine

    Dilip R. Gunturu; Mohammed Hassan; Deepa Bedi et al.

    Current Oncology, Vol. 31 No. 3 · 2024 · English · DOAJ Scopus

    Precision cancer medicine primarily aims to identify individual patient genomic variations and exploit vulnerabilities in cancer cells to select suitable patients for specific drugs. These genomic features are commonly determined by gene sequencing prior to therapy, to identify individuals who…

  5. Journal Article

    Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer

    Anusha Angajala; Essynce Mothershed; Melissa B. Davis et al.

    Translational Oncology, Vol. 12 No. 3 · 2019 · English · DOAJ Scopus

    PURPOSE: Despite the availability of current standards of care treatments for triple negative breast cancer (TNBC), many patients still die from this disease. Quadruple negative tumors, which are TNBC tumors that lack androgen receptor (AR), represent a more aggressive subtype of TNBC; however, the…

  6. Journal Article

    Phage Ligands for Identification of Mesenchymal-Like Breast Cancer Cells and Cancer-Associated Fibroblasts

    Kelvin M. Jones; Balasubramanyam Karanam; Jacqueline Jones-Triche et al.

    Frontiers in Oncology, Vol. 8 · 2018 · English · DOAJ Scopus

    Epithelial to mesenchymal transition (EMT) is believed to be crucial for primary tumors to escape their original residence and invade and metastasize. To properly define EMT, there is a need for ligands that can identify this phenomenon in tumor tissue and invivo. A phage-display selection…

  7. Journal Article

    Characterization of Canine Adenovirus Type 2 Virus Infection Pattern in Canine and Human Cell Lines

    Madison D. Hogans; Will P. Kretzschmar; Theresa A. Higgins et al.

    Advances in Virology, Vol. 2022 · 2022 · English · DOAJ Scopus

    Canine adenovirus type 2 (CAV2) is a nonhuman adenovirus with a known ability to infect human and canine cells. The cell surface receptors involved in CAV2 transduction are still unknown. Identification of these would provide valuable information to develop enhanced gene delivery tools and better…

  8. Journal Article

    Nanobody-based CTLA4 inhibitors for immune checkpoint blockade therapy of canine cancer patients

    Jonathan Marable; Damien Ruiz; Anil K. Jaiswal et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Cancer is the leading cause of death in the geriatric dog population. Currently, the use of immune checkpoint inhibitors (ICIs) such as anti-CTLA4 antibodies has markedly improved the prognosis of several cancers in their advanced stages. However, ICIs targeting CTLA4 blockade to treat…

  9. Journal Article

    Development of OX40 agonists for canine cancer immunotherapy

    Damien Ruiz; Chloe Haynes; Jonathan Marable et al.

    iScience, Vol. 25 No. 10 · 2022 · English · DOAJ Scopus

    Summary: Recent breakthroughs in cancer immunotherapy have provided unprecedented clinical benefits to human cancer patients. Cancer is also one of the most common causes of death in pet dogs. Thus, canine-specific immune therapies targeting similar signaling pathways can provide better treatment…

  10. Journal Article

    MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans

    Anusha Angajala; Hughley Raymond; Aliyu Muhammad et al.

    Scientific Reports, Vol. 12 No. 1 · 2022 · English · DOAJ Scopus

    Abstract We previously found that QNBC tumors are more frequent in African Americans compared to TNBC tumors. To characterize this subtype further, we sought to determine the miRNA–mRNA profile in QNBC patients based on race. Both miRNA and mRNA expression data were analyzed from TCGA and validated…